Phenanthroline

Phenanthroline

SCHEMBL675150

[Ag].c1cnc2c(c1)ccc1cccnc12

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.94
CCR8 P51685 5/20 0.94
LMNA P02545 4/20 0.94
CCR5 P51681 3/20 0.94
KDM4E B2RXH2 3/20 0.94
MMP2 P08253 2/20 0.94
TSHR P16473 2/20 0.94
MAPT P10636 2/20 0.94
HTT P42858 2/20 0.94
SMN1; SMN2 Q16637 2/20 0.94
TDP1 Q9NUW8 2/20 0.94
GMNN O75496 1/20 0.94
TP53 P04637 1/20 0.94
HSP90AA1 P07900 1/20 0.94
CYP3A4 P08684 1/20 0.94
CYP2D6 P10635 1/20 0.94
MMP9 P14780 1/20 0.94
ALOX15 P16050 1/20 0.94
NFKB1 P19838 1/20 0.94
MMP8 P22894 1/20 0.94

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenanthroline SCHEMBL29354015 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL29367277 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL8845760 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL8312 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL22982126 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL22462277 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL21044608 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL21300488 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL21060516 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL3790396 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10584202-B2 Photovoltaic element TORAY INDUSTRIES, INC (JP) 2020-03-10 US claimed
EP-3133659-B1 METHOD FOR FORMING AN ELECTRON EXTRACTION LAYER TORAY INDUSTRIES (JP) 2019-05-22 EP claimed
CN-1231122-C Process of preparing antibacterial material for microperfusion irrigator UNIV XI AN JIAOTONG (CN) 2005-12-14 CN claimed
CN-1454472-A Process of preparing antibacterial material for microperfusion irrigator UNIV XI AN JIAOTONG (CN) 2003-11-12 CN claimed
WO-2022044589-A1 LIGHT RECEPTION/EMISSION ELEMENT, AND ELECTRONIC DEVICE AND BIOLOGICAL SENSING DEVICE USING SAME 東レ株式会社 2022-03-03 WO disclosed
US-20220013742-A1 ORGANIC SOLAR CELL MODULE, METHOD OF MANUFACTURING THE SAME, ELECTRONIC DEVICE, OPTICAL SENSOR, AND IMAGING DEVICE TORAY INDUSTRIES, INC. (JP) 2022-01-13 US disclosed
EP-3890040-A1 ORGANIC SOLAR CELL MODULE, METHOD FOR MANUFACTURING SAME, ELECTRONIC DEVICE, OPTICAL SENSOR, AND IMAGING DEVICE Toray Industries, Inc. (JP) 2021-10-06 EP disclosed
CN-112970129-A Organic solar cell module, method for manufacturing same, electronic device, optical sensor, and imaging device 东丽株式会社 2021-06-15 CN disclosed
US-10584202-B2 Photovoltaic element TORAY INDUSTRIES, INC (JP) 2020-03-10 US disclosed
US-10388876-B2 Organic semiconductor composition, photovoltaic element, photoelectric conversion device, and method of manufacturing photovoltaic element TORAY INDUSTRIES, INC. (JP) 2019-08-20 US disclosed
EP-3222666-B1 ORGANIC SEMICONDUCTOR COMPOSITION, AND METHOD FOR MANUFACTURING PHOTOVOLTAIC ELEMENT TORAY INDUSTRIES (JP) 2019-07-10 EP disclosed
CN-106463627-B Photovoltaic element 东丽株式会社 2019-06-28 CN disclosed
CN-101754686-A Methods and compositions comprising high valent silver for increasing seed germination INNOVOTECH INC 2010-06-23 CN disclosed
US-20100129466-A1 COMPOSITIONS AND METHODS FOR TREATING PLANTS INOVOTECH, INC. (CA) 2010-05-27 US disclosed
EP-2162000-A1 METHODS AND COMPOSITIONS COMPRISING HIGH VALENCY SILVER FOR INCREASING SEED GERMINATION Innovotech Inc. (CA) 2010-03-17 EP disclosed
EP-2034841-A1 METHODS AND COMPOSITIONS FOR TREATING BIOFILMS Innovotech, Inc. (CA) 2009-03-18 EP disclosed
WO-2008148221-A1 METHODS AND COMPOSITIONS COMPRISING HIGH VALENCY SILVER FOR INCREASING SEED GERMINATION INNOVOTECH INC. (CA) 2008-12-11 WO disclosed
WO-2007147267-A1 METHODS AND COMPOSITIONS FOR TREATING BIOFILMS INNOVOTECH, INC. (CA) 2007-12-27 WO disclosed
CN-1231122-C Process of preparing antibacterial material for microperfusion irrigator UNIV XI AN JIAOTONG (CN) 2005-12-14 CN disclosed
CN-1454472-A Process of preparing antibacterial material for microperfusion irrigator UNIV XI AN JIAOTONG (CN) 2003-11-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10388876-B2 Organic semiconductor composition, photovoltaic element, photoelectric conversion device, and method of manufacturing photovoltaic element TYR, ALK, PORCN CCR1 4280/4885CCR8 4184/4885LMNA 3426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.